PNC Financial Services Group’s Castle Biosciences CSTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4K Sell
163
-383
-70% -$12.5K ﹤0.01% 4365
2025
Q4
$21.2K Buy
546
+431
+375% +$13.9K ﹤0.01% 3625
2025
Q3
$2.62K Buy
115
+5
+5% +$102 ﹤0.01% 4425
2025
Q2
$2.25K Sell
110
-10
-8% -$185 ﹤0.01% 4379
2025
Q1
$2.4K Buy
+120
New +$2.97K ﹤0.01% 4293
2024
Q2
Sell
-38
Closed -$842 4783
2024
Q1
$842 Hold
38
﹤0.01% 4403
2023
Q4
$820 Sell
38
-2,226
-98% -$39.2K ﹤0.01% 4345
2023
Q3
$38.2K Sell
2,264
-337
-13% -$5.89K ﹤0.01% 3093
2023
Q2
$35.7K Buy
2,601
+5
+0.2% +$101 ﹤0.01% 3250
2023
Q1
$59K Sell
2,596
-154
-6% -$3.76K ﹤0.01% 2888
2022
Q4
$64.7K Sell
2,750
-985
-26% -$22.8K ﹤0.01% 2823
2022
Q3
$97K Buy
3,735
+41
+1% +$1.15K ﹤0.01% 2549
2022
Q2
$81K Sell
3,694
-51
-1% -$1.19K ﹤0.01% 2704
2022
Q1
$168K Buy
3,745
+1,290
+53% +$53.3K ﹤0.01% 2380
2021
Q4
$105K Buy
2,455
+960
+64% +$50.2K ﹤0.01% 2651
2021
Q3
$99K Buy
1,495
+147
+11% +$10.3K ﹤0.01% 2657
2021
Q2
$99K Sell
1,348
-53
-4% -$3.5K ﹤0.01% 2664
2021
Q1
$96K Buy
1,401
+51
+4% +$3.83K ﹤0.01% 2597
2020
Q4
$91K Buy
+1,350
New +$73.2K ﹤0.01% 2549

Other funds holding CSTL

PNC Financial Services Group's CSTL Position: Q1 2026 in Review

PNC Financial Services Group reduced its Castle Biosciences (CSTL) stake by 70% in Q1 2026, selling an estimated $12.5K and leaving 163 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #4365.

PNC Financial Services Group first reported a position in CSTL in Q4 2020 and has held it in 19 quarters since. The position peaked at $168K in Q1 2022. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.

  • PNC Financial Services Group held 163 shares of Castle Biosciences worth $4K as of Q1 2026.
  • PNC Financial Services Group sold 383 Castle Biosciences shares in Q1 2026, an estimated $12.5K.
  • Castle Biosciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #4365 holding.
  • PNC Financial Services Group first reported a position in Castle Biosciences in Q4 2020 and has held it in 19 quarters since.
  • PNC Financial Services Group's Castle Biosciences position peaked at $168K in Q1 2022.
  • 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.